ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9397
-0.26%
Brent Oil
83.495
0.45%
Bitcoin
65,137.28
1.78%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. NeuroMetrix Inc (NURO)

  7. NeuroMetrix Inc (NURO) Noticias

NURO NeuroMetrix Inc

4.30
0.00 (0.00%)
Pre Mercado
Última actualización: 03:05:11
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
NeuroMetrix Inc NURO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 4.30 03:05:11
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.30
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
19/4/202407:00GLOBENeuroMetrix Announces Steps Taken to Enhance Shareholder..
14/3/202408:00GLOBENeuroMetrix Announces Publication of Study Demonstrating..
13/3/202408:00GLOBENeuroMetrix announces that over 2000 patients with..
06/3/202416:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202416:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202416:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202416:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202415:12EDGAR2Form SC 13D/A - General statement of acquisition of..
01/3/202416:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202415:45EDGAR2Form 8-K/A - Current report: [Amend]
27/2/202415:00EDGAR2Form SC 13D - General statement of acquisition of beneficial..
26/2/202416:41EDGAR2Form SC 13D - General statement of acquisition of beneficial..
22/2/202406:15EDGAR2Form 8-K - Current report
22/2/202406:00GLOBENeuroMetrix Reports Q4 and Full Year 2023 Business..
20/2/202413:49EDGAR2Form SCHEDULE 13G - Statement of acquisition of beneficial..
15/2/202408:00GLOBENeuroMetrix, Inc. Announces Date for Fourth Quarter and Full..
13/2/202408:00GLOBENeuroMetrix Announces Review of Strategic Options to Promote..
12/12/202308:00GLOBENeuroMetrix Reports Encouraging Results from Pilot Clinical..
05/12/202308:00GLOBENeuroMetrix Announces Peer-Reviewed Publication of Phase 2..
20/11/202308:33EDGAR2Form 8-K - Current report
20/11/202308:00GLOBENeuroMetrix Announces One-for-Eight Reverse Stock Split
26/10/202315:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/10/202306:11EDGAR2Form 8-K - Current report
26/10/202306:00GLOBENeuroMetrix Reports Q3 2023 Business Highlights
23/10/202310:13GLOBENeuroMetrix, Inc. Announces Date for Third Quarter 2023..
20/10/202313:59EDGAR2Form 8-K - Current report
02/10/202308:00GLOBENeuroMetrix and the National Fibromyalgia Association to..
11/9/202306:59EDGAR2Form DEF 14A - Other definitive proxy statements
11/8/202316:11EDGAR2Form 8-K - Current report
04/8/202317:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202317:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202317:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202316:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/7/202315:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/7/202315:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
27/7/202306:24EDGAR2Form 8-K - Current report
27/7/202306:00GLOBENeuroMetrix Reports Q2 2023 Business Highlights
20/7/202312:00GLOBENeuroMetrix, Inc. Announces Date for Second Quarter 2023..
11/7/202308:00GLOBENeuroMetrix Announces Sales Force Expansion for Quell..
28/6/202308:00GLOBERecent Publications Demonstrate Utility of DPNCheck® for..
07/6/202308:00GLOBEDiabetic Peripheral Neuropathy Screening That Includes..
31/5/202308:00GLOBEQuell® Demonstrates Encouraging Clinical Trial Results in..

Su Consulta Reciente

NASDAQ
NURO
NeuroMetrix
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados